MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$3,927K
Free Cash flow
$8,576K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from term loan, net of ...
Accounts receivable
Stock-based compensation
Others
Negative Cash Flow Breakdown
Repayment of long-term debt
Accounts payable
Taxes receivable and payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-703
-495
5,020
779
Depreciation and amortization
1,064
1,064
1,078
1,081
Goodwill impairment
-
-
-
0
Impairment charges
-
-
368
-
Bad debt expense
-
-
0
0
Stock-based compensation
2,208
1,828
1,960
1,956
Amortization of debt issuance costs
277
358
325
174
Accounts receivable
-7,193
-5,763
5,525
-1,285
Prepaid expenses and other assets
-209
290
19
-510
Accounts payable
-1,743
1,430
-401
55
Revenue share payable
-142
-2,131
757
-262
Accrued expenses and other liabilities
1,799
-7,989
1,461
-2,225
Operating lease liabilities
0
-2
-3
6
Deferred tax liabilities
134
50
-1,214
-1,033
Deferred loan fees
-
-
250
-
Taxes receivable and payable
-1,457
-119
995
-1,101
Deferred revenue
40
166
108
-89
Net cash provided by operating activities
8,611
-467
7,088
3,202
Purchases of property and equipment
35
21
11
10
Capitalized software development costs
0
0
35
0
Net cash used in investing activities
-35
-21
206
-10
Cash paid for employee withholding taxes related to the vesting of restricted stock units
46
17
962
96
Proceeds from exercise of stock options, net of cash paid for withholding taxes
-
-
14
338
Proceeds from term loan, net of issuance costs
24,298
-
-
-
Repayment of long-term debt
28,912
2,691
2,500
500
Net cash used in financing activities
-4,660
-2,708
-3,448
-258
Effect of exchange rate changes on cash and cash equivalents
11
-
-
-
Net increase in cash and cash equivalents
3,927
-3,196
3,846
2,934
Cash and cash equivalents - beginning of period
20,169
23,365
19,519
13,380
Cash and cash equivalents - end of period
24,096
20,169
23,365
19,519
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accounts receivable
-$7,193K
(-53.04%↓ Y/Y)
Stock-based compensation
$2,208K
(-27.51%↓ Y/Y)
Accrued expenses and
other liabilities
$1,799K
(-56.52%↓ Y/Y)
Depreciation and
amortization
$1,064K
(-50.92%↓ Y/Y)
Amortization of debt issuance
costs
$277K
(-54.66%↓ Y/Y)
Prepaid expenses and
other assets
-$209K
(-121.82%↓ Y/Y)
Deferred revenue
$40K
(263.64%↑ Y/Y)
Net cash provided by
operating activities
$8,611K
(2.21%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$11K
Canceled cashflow
$4,179K
Net increase in cash
and cash...
$3,927K
(22.53%↑ Y/Y)
Canceled cashflow
$4,695K
Accounts payable
-$1,743K
(-901.72%↓ Y/Y)
Taxes receivable and
payable
-$1,457K
(-51.14%↓ Y/Y)
Net loss
-$703K
(-5.40%↓ Y/Y)
Revenue share payable
-$142K
(94.23%↑ Y/Y)
Deferred tax liabilities
$134K
(-87.03%↓ Y/Y)
Proceeds from term loan,
net of issuance...
$24,298K
Net cash used in
financing activities
-$4,660K
(8.48%↑ Y/Y)
Net cash used in
investing activities
-$35K
(72.66%↑ Y/Y)
Canceled cashflow
$24,298K
Repayment of long-term
debt
$28,912K
(478.24%↑ Y/Y)
Purchases of property and
equipment
$35K
(-5.41%↓ Y/Y)
Cash paid for
employee withholding...
$46K
(-50.00%↓ Y/Y)
Buy us a coffee
OptimizeRx Corp (OPRX)
OptimizeRx Corp (OPRX)